Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Income Quality Over TimeStable
Percentile Rank0
3Y CAGR-7.1%
5Y CAGR-9.0%
Studio
Year-over-Year Change

Quality of reported income

3Y CAGR
-7.1%/yr
vs -3.4%/yr prior
5Y CAGR
-9.0%/yr
Consistent
Acceleration
-3.7pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineStable
PeriodValueYoY Change
20240.56-3.7%
20230.58-31.6%
20220.85+21.8%
20210.70+5.8%
20200.66-26.5%
20190.90-4.0%
20180.94+16.7%
20170.80-